The good news is, this patent nonetheless could be challenged, even though the process will be expensive, and there is no warranty that everyone would invest the numerous thousands required to carry this to courtroom.In many respects, the for-revenue copyright discipline is behaving the same as other biotech organizations have in advance of—they�